Reuters logo
10 months ago
BRIEF-Biofrontera initiates U.S. commercial launch of Ameluz for actinic keratosis
October 18, 2016 / 12:36 PM / 10 months ago

BRIEF-Biofrontera initiates U.S. commercial launch of Ameluz for actinic keratosis

Oct 18 (Reuters) - Biofrontera AG :

* Initiates U.S. commercial launch Of Ameluz for actinic keratosis Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below